Senate LDA lobbying filing
OLIN CORPORATION
Reported income
not reported
Reported expenses
$260.0K
Tracked program mentions2
Quoted activity text is clipped to a short extract; each filing’s full description is under Lobbying activities below.
Issues related to pharmacy benefit managers pertaining to H.R. 4317 - PBM Reform Act of 2025; Issues related to…
Issues related to Department of Defense and NDAA appropriations pertaining to the Lake City Funding Provision; Issues…
Lobbying activities6
Chemicals/Chemical IndustryCHM
Issues related to asbestos; Issues related to reform of the Frank R. Lautenberg Chemical Safety for the 21st Century Act (PL 114-182); Issues related to the Epoxy Resin anti-dumping and countervailing duty cases pending at International Trade Commission.
Environment/SuperfundENV
Issues related to the 2012 PVC MACT rule (National Emissions Standards for Hazardous Air Pollutants; Polyvinyl Chloride; and Copolymers Production).
Firearms/Guns/AmmunitionFIR
Issues related to Department of Defense and NDAA appropriations pertaining to the Lake City Funding Provision; Issues related to the National Defense Authorization Act for Fiscal Year 2026 (PL 119-60).
Health IssuesHCR
Issues related to pharmacy benefit managers pertaining to H.R. 4317 - PBM Reform Act of 2025; Issues related to pharmacy benefit managers pertaining to S. 3345 - PBM Price Transparency and Accountability Act.
TransportationTRA
Issues related to railroad safety and competition and proposed merger of Class I railroads.
Trade (domestic/foreign)TRD
Issues related to the Section 232 Copper Tariff rule issued August 1, 2025.
Lobbyists1
- MICHAEL MEENAN
Source: U.S. Senate Lobbying Disclosure Act database. Dollar figures (underlined) cite the filing record on lda.senate.gov — click to view the citation. Amounts shown as “not reported” are absent from the filing itself.